Teaching medicinal chemistry to meet outcome objectives for pharmacy students

American Journal of Pharmaceutical Education

Volumn 63, Issue 1, 1999, Pages 34-40

  Alsharif, Naser Z ^a   Destache, Christopher J ^a   Roche, Victoria F ^a  

^a CREIGHTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0011765371     PISSN: 00029459     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. "The Role of the Pharmacist in Comprehensive Medication Use Management," APhA Professional Affairs Department, Washington DC(1992).
2. Commission to Implement Change in Pharmaceutical Education, "Background paper II: Entry level, curricular outcomes, curricular content and educational process," Am. J. Pharm. Educ, 57, 377-385(1993).
3. Accreditation Standards and Guidelines for the Professional Program in Pharmacy Leading to the Doctor of Pharmacy Degree, American Council on Pharmaceutical Education, Chicago IL (1997).
4. Alsharif, N.Z., Theesen, K.A. and Roche, V.F., "Structurally-based therapeutic evaluation: A therapeutic and practical approach to teaching medicinal chemistry," Am. J. Pharm. Educ., 61, 55-60(1997).
5. Mitscher, L.A., "Antibiotics and antimicrobial agents," in Principles of Medicinal Chemistry, 4th. ed., (edit., Foye, W.O., Lemke, T.L. and Williams, D.A.), Williams and Wilkins, Baltimore MD (1995) pp. 770-787.
6. Mandell, G.L. and Petri, W.A., "Chemotherapy of microbial diseases," in Pharmacological Basis of Therapeutics, 9th. ed., (edit., Hardman, J.G. and Limbird, L.E.), McGraw-Hill, New York (1996) pp.1057-1102.
7. Domagala, J.M., "Structure-activity and structure-side-effect relationships for the quinolone antibacterials," J. Antimicrob. Chemother., 33, 685-706(1994).
8. Mizuki, Y., Fujiwara, I. and Tamaguchi, T., "Pharmacokinetic interactions related to the chemical structures of fluoroquinolones," J. Antimicrob. Chemother., 37(A), 41-55(1996).
9. Radandt, J.M., Machbanks, C.R. and Dudley, M.N., "Interactions of fluoroquinolones with other drugs: Mechanisms, variability, clinical significance, and management," Pharmacotherapy., 14, 272-284(1992).
10. Martinez, L.J., Sik, R.H. and Chingell, C.F., "Fluoroquinolone antimicrobials: Singlet oxygen, superoxide and phototoxicity," Photochem. Photobiol., 67, 399-403(1998).
11. Rosen, J.E., Chen, D., Prahalad, A.K., Spratt, T.E., Schluter, G. and Williams, G.M., "A fluoroquinolone antibiotic with a methoxy group at the 8 position yields reduced generation of 8-oxo-7,8-dihydro-2′-deoxyguanosine after ultraviolet-A irradiation," Toxicol. Appl. Pharmacol., 145, 381-387(1997).
12. Wijnands, W.J. and Vree, T.B., "Interaction between the fluoroquinolones and the bronchodilator theophylline," J. Antimicrob. Chemother., 22(C), 109-114(1988).
13. Knodel, L.C. and Kraynak M.A., "Sexually transmitted diseases," in Pharmacotherapy: A Pathological Approach, 3rd. ed., (edit., DiPiro, J.T., Talbert, R.L., Yee, G.C., Matzke, G.R., Wells, B.G. and Posey, L.M.), Appleton & Lange, Samford, Connecticut (1997) p. 2204.